Let's transform cardiovascular care together
If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.
Under the new CMS ACCESS Model, eligible Original Medicare beneficiaries can receive clinician-guided care and medical-grade connected tools to lower health risks at $0 out-of-pocket cost.
MOUNTAIN VIEW, Calif., September 15, 2026– AliveCor, the global leader in AI-powered cardiology, today announced KardiaACCESS, a 10-year initiative under the Centers for Medicare & Medicaid Services (CMS) Innovation Center's ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions). Designed to go beyond passive monitoring, KardiaACCESS provides clinician-guided, outcome-aligned care to help people actively lower blood pressure, balance blood sugar, and manage their overall cardio-kidney-metabolic health.
Managing chronic conditions often means brief doctor visits and trying to connect the dots alone. Regular monitoring is the key to identifying what is happening with your heart, and the KardiaACCESS program serves as the bridge to communicate with care teams both in and out of the doctor's office. KardiaACCESS treats connected health systems together—addressing the links between blood pressure, diabetes, lipids, and kidney function to deliver real health improvements and keep people out of the hospital.
According to the American Heart Association, more than 70% of U.S. adults aged 60 to 79 live with cardiovascular disease. Furthermore, the Centers for Disease Control and Prevention (CDC) reports that three in four U.S. adults have at least one chronic condition, with interconnected issues like high blood pressure and diabetes serving as the primary drivers of chronic kidney and heart disease.
“We’ve been helping patients manage heart health conditions for over a decade. We know the center of chronic disease management often starts at the heart, and we are uniquely positioned to connect the dots across cardio-kidney-metabolic health. With KardiaACCESS, we provide active clinical guidance and medical-grade tools to help people manage their blood pressure, diabetes, lipids, and weight—empowering them to improve their real health numbers, reduce risks, and protect their hearts from home.”
Program DetailsKardiaACCESS is currently available to eligible Original Medicare (Part B) beneficiaries in 48 states, with expansion to Arkansas and South Carolina coming soon.
As the pioneer of personal, medical-grade electrocardiogram (ECG) technology, AliveCor brings unmatched clinical scale and validation to the ACCESS model. To date, the company’s technology has supported more than 6.4 million patients globally and recorded over 400 million ECGs—a figure that continues to grow by more than one million recordings each week. Available in more than 40 countries, AliveCor’s solutions are backed by more than 250 peer-reviewed publications and are cleared to detect 39 distinct cardiac conditions, including life-threatening heart attacks and ischemia.
To learn more about KardiaACCESS and to check coverage and eligibility visit https://kardia.com/access.
KardiaACCESS is provided by Kardia Medical Group, a clinical partner of AliveCor, in participation with the Centers for Medicare & Medicaid Services (CMS) ACCESS Model. KardiaACCESS is an outcome-aligned care program covered under Medicare Part B for eligible beneficiaries.
Centers for Medicare & Medicaid Services (CMS) and KardiaACCESS are trademarks or registered trademarks. All care services and clinical evaluations are rendered under Cardiac Health Medical Group.
About AliveCor
AliveCor, Inc., the leading provider of FDA-cleared personal electrocardiogram (ECG) devices, is transforming cardiology with its medical-grade AI solutions. The company was named to the inaugural TIME World’s Top Health Tech Companies 2025 list – recognition of its commitment to delivering innovative devices and services that empower patients and physicians with personalized, actionable heart data. With over 350 million ECGs recorded, the company’s Kardia devices are the most clinically validated personal ECGs in the world and can remotely detect six of the most common heart arrhythmias in just 30 seconds. The company’s latest offering, Kardia 12L ECG System, powered by KAI 12L cleared to detect 39 cardiac conditions (with determination availability varying by geography), was designed exclusively for use by healthcare providers. AliveCor’s enterprise platform allows third-party providers to manage their patients’ and customers’ heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies, addressing gaps in care and improving the treatment experience for patients across a range of disease areas. AliveCor is a privately held company headquartered in Mountain View, Calif. For more information, visit alivecor.com and follow us on LinkedIn, X, Instagram and Facebook.
Media Contact
Morgan Mathis
Director of Corporate Communications, AliveCor
press@alivecor.com
Let's transform cardiovascular care together
If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.